AccuSite Injection: Completed enrollment in its 390-patient Phase III trial

Matrix Pharmaceutical Inc. (MATX) Product: AccuSite Injection, consisting of fluorouracil and epinephrine in a biodegradable collagen matrix Indication: Genital warts Status: Completed enrollment in ...